CME Group Inc. $CME Holdings Lessened by Fiera Capital Corp

Fiera Capital Corp cut its position in CME Group Inc. (NASDAQ:CME) by 1.7% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 2,744,106 shares of the financial services provider’s stock after selling 46,486 shares during the quarter. CME Group accounts for 2.4% of Fiera Capital Corp’s portfolio, making the stock its 9th largest position. Fiera Capital Corp owned 0.76% of CME Group worth $741,430,000 at the end of the most recent quarter.

A number of other large investors have also added to or reduced their stakes in the company. Empowered Funds LLC grew its stake in shares of CME Group by 11.5% during the first quarter. Empowered Funds LLC now owns 10,027 shares of the financial services provider’s stock valued at $2,660,000 after acquiring an additional 1,037 shares in the last quarter. Whittier Trust Co. of Nevada Inc. boosted its holdings in CME Group by 0.8% in the second quarter. Whittier Trust Co. of Nevada Inc. now owns 5,021 shares of the financial services provider’s stock valued at $1,384,000 after purchasing an additional 38 shares during the last quarter. D.A. Davidson & CO. grew its stake in CME Group by 0.4% during the 2nd quarter. D.A. Davidson & CO. now owns 31,025 shares of the financial services provider’s stock valued at $8,551,000 after purchasing an additional 131 shares in the last quarter. Rehmann Capital Advisory Group purchased a new stake in CME Group during the 2nd quarter worth approximately $237,000. Finally, Forum Financial Management LP raised its position in shares of CME Group by 8.0% in the 2nd quarter. Forum Financial Management LP now owns 8,031 shares of the financial services provider’s stock valued at $2,214,000 after purchasing an additional 593 shares in the last quarter. 87.75% of the stock is owned by institutional investors and hedge funds.

CME Group Stock Performance

Shares of NASDAQ CME opened at $303.91 on Friday. The company has a quick ratio of 1.02, a current ratio of 1.03 and a debt-to-equity ratio of 0.12. The firm’s 50-day moving average price is $282.49 and its two-hundred day moving average price is $274.70. CME Group Inc. has a 52-week low of $246.68 and a 52-week high of $309.35. The stock has a market capitalization of $109.59 billion, a P/E ratio of 27.23, a P/E/G ratio of 3.54 and a beta of 0.27.

CME Group (NASDAQ:CME) last announced its quarterly earnings results on Wednesday, February 4th. The financial services provider reported $2.77 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.75 by $0.02. The business had revenue of $1.65 billion for the quarter, compared to the consensus estimate of $1.64 billion. CME Group had a return on equity of 14.65% and a net margin of 62.45%.The business’s revenue was up 8.1% on a year-over-year basis. During the same quarter last year, the business posted $2.52 EPS. As a group, sell-side analysts forecast that CME Group Inc. will post 10.49 earnings per share for the current year.

CME Group Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Thursday, March 26th. Shareholders of record on Tuesday, March 10th will be paid a dividend of $1.30 per share. This represents a $5.20 dividend on an annualized basis and a yield of 1.7%. The ex-dividend date of this dividend is Tuesday, March 10th. This is a positive change from CME Group’s previous quarterly dividend of $1.25. CME Group’s dividend payout ratio (DPR) is presently 44.80%.

Wall Street Analyst Weigh In

A number of research firms have recently weighed in on CME. Deutsche Bank Aktiengesellschaft raised their price target on shares of CME Group from $312.00 to $316.00 and gave the stock a “buy” rating in a research report on Thursday, February 5th. Bank of America increased their price objective on shares of CME Group from $201.00 to $209.00 in a research note on Wednesday, December 10th. JPMorgan Chase & Co. boosted their target price on shares of CME Group from $262.00 to $266.00 and gave the stock an “underweight” rating in a research report on Thursday, February 5th. Raymond James Financial cut their target price on shares of CME Group from $311.00 to $310.00 and set an “outperform” rating on the stock in a research note on Wednesday, February 4th. Finally, TD Cowen lifted their price target on CME Group from $305.00 to $328.00 and gave the stock a “buy” rating in a research note on Thursday, February 5th. Nine research analysts have rated the stock with a Buy rating, six have given a Hold rating and three have issued a Sell rating to the company. According to data from MarketBeat.com, CME Group presently has an average rating of “Hold” and a consensus target price of $299.53.

CME Group News Roundup

Here are the key news stories impacting CME Group this week:

• Positive Sentiment: CME will launch round‑the‑clock trading for crypto futures and options on May 29, expanding access for institutional clients and reducing timing gaps with spot crypto venues. PR Newswire: CME Group to Launch 24/7 Cryptocurrency Futures and Options Trading on May 29
• Positive Sentiment: Company cites record crypto notional volume and rising ADV in 2025–2026, suggesting the 24/7 shift could raise trading volumes and transaction-related revenue. Blockonomi: CME Group Set to Offer Round-the-Clock Crypto Futures Trading in May
• Positive Sentiment: Market commentary and trade desks are highlighting CME as a beneficiary of volatility-driven flows and reliable income generation, with some analysts/strategists listing CME among top picks for navigating market swings. Seeking Alpha: My Picks To Monetize Today’s Market Chaos
• Neutral Sentiment: Analyst consensus remains a “Hold,” reflecting tempered expectations despite product expansion; that keeps upside tied to execution and volume pickup. American Banking News: CME Group Receives Consensus Recommendation of “Hold”
• Neutral Sentiment: Short‑interest reporting for mid‑February shows effectively zero/unclear reads (data noise), so there’s no clear short‑base pressure implied by the available short‑interest figures.
• Negative Sentiment: The 24/7 rollout is pending regulatory review and requires smooth operational implementation; delays, regulatory objections, or execution issues (clearing/reporting during expanded hours) could weigh on sentiment if they occur. Cointelegraph: CME targets May launch for 24/7 crypto derivatives trading

Insiders Place Their Bets

In other news, CEO Terrence A. Duffy sold 25,000 shares of CME Group stock in a transaction that occurred on Thursday, December 11th. The stock was sold at an average price of $269.55, for a total transaction of $6,738,750.00. Following the sale, the chief executive officer owned 65,804 shares of the company’s stock, valued at approximately $17,737,468.20. The trade was a 27.53% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, Director Dennis Suskind sold 748 shares of the firm’s stock in a transaction that occurred on Friday, February 6th. The shares were sold at an average price of $300.00, for a total value of $224,400.00. Following the completion of the sale, the director owned 2,699 shares in the company, valued at approximately $809,700. This represents a 21.70% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. 0.30% of the stock is owned by insiders.

CME Group Company Profile

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.